What are the features of Genetoxicity Testing Services? The genotoxicity testing of new chemical entities is an integral part of the drug development process and is a regulatory requirement prior to the approval of new drugs. By determing genotoxicity at an early stage in drug discovery rather than during regulatory assessment, the likelihood of late stage failures is reduced.

Creative Bioarray offers a range of genotoxicity testing (non-GLP) services as recommended by regulatory agencies.

https://dda. creative-bioarray. com/genotoxicity. html